» Articles » PMID: 2015149

Optimal Dose of Lignocaine for Preventing Pain on Injection of Propofol

Overview
Journal Br J Anaesth
Publisher Elsevier
Specialty Anesthesiology
Date 1991 Mar 1
PMID 2015149
Citations 16
Authors
Affiliations
Soon will be listed here.
Abstract

The purpose of this study was to define the optimum dose of lignocaine required to reduce pain on injection of propofol. We conducted a prospective, randomized, double-blind trial on 310 patients undergoing anaesthesia. Patients were allocated to four groups according to the lignocaine dosage: group A (control), no lignocaine; group B, lignocaine 0.1 mg kg-1; group C, lignocaine 0.2 mg kg-1; group D, lignocaine 0.4 mg kg-1. Our results showed that a dose of lignocaine 0.1 mg kg-1 significantly reduced the incidence of pain and that there was no improvement when the dose was increased.

Citing Articles

Comparison between patient state index, bispectral index, and clinical parameters for propofol induction in Indian patients: A prospective study.

Shajahan M, Agrawal S, Singla D J Anaesthesiol Clin Pharmacol. 2024; 39(4):544-549.

PMID: 38269185 PMC: 10805218. DOI: 10.4103/joacp.joacp_10_22.


High-Loading Self-Assembling Peptide Nanoparticles as a Lipid-Free Carrier for Hydrophobic General Anesthetics.

Liu J, Peng F, Kang Y, Gong D, Fan J, Zhang W Int J Nanomedicine. 2021; 16:5317-5331.

PMID: 34408412 PMC: 8364852. DOI: 10.2147/IJN.S315310.


A comparative study of attenuation of propofol-induced pain by lignocaine, ondansetron, and ramosetron.

Sumalatha G, Dodawad R, Pandarpurkar S, Jajee P Indian J Anaesth. 2016; 60(1):25-9.

PMID: 26962251 PMC: 4782419. DOI: 10.4103/0019-5049.174810.


Lidocaine for reducing propofol-induced pain on induction of anaesthesia in adults.

Euasobhon P, Dej-Arkom S, Siriussawakul A, Muangman S, Sriraj W, Pattanittum P Cochrane Database Syst Rev. 2016; 2:CD007874.

PMID: 26888026 PMC: 6463799. DOI: 10.1002/14651858.CD007874.pub2.


5-HT3 Receptor Antagonists for Propofol Injection Pain: A Meta-Analysis of Randomized Controlled Trials.

Wang W, Zhou L, Wu L, Wang T, Zhang C, Sun L Clin Drug Investig. 2016; 36(4):243-53.

PMID: 26860485 DOI: 10.1007/s40261-016-0375-1.